- Home
- MRSN vs ICG Comparison
MRSN vs ICG Comparison
Compare MRSN & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- ICG
- Stock Information
- Founded
- MRSN 2001
- ICG 2017
- Country
- MRSN United States
- ICG China
- Employees
- MRSN N/A
- ICG N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- ICG Semiconductors
- Sector
- MRSN Health Care
- ICG Technology
- Exchange
- MRSN Nasdaq
- ICG Nasdaq
- Market Cap
- MRSN 40.7M
- ICG 105.7M
- IPO Year
- MRSN 2017
- ICG 2023
- Fundamental
- Price
- MRSN $0.29
- ICG $2.01
- Analyst Decision
- MRSN Strong Buy
- ICG Strong Buy
- Analyst Count
- MRSN 5
- ICG 2
- Target Price
- MRSN $5.75
- ICG $9.25
- AVG Volume (30 Days)
- MRSN 2.8M
- ICG 231.6K
- Earning Date
- MRSN 08-12-2025
- ICG 08-14-2025
- Dividend Yield
- MRSN N/A
- ICG N/A
- EPS Growth
- MRSN N/A
- ICG N/A
- EPS
- MRSN N/A
- ICG 0.07
- Revenue
- MRSN $34,006,000.00
- ICG $53,729,346.00
- Revenue This Year
- MRSN N/A
- ICG N/A
- Revenue Next Year
- MRSN $1.30
- ICG $141.94
- P/E Ratio
- MRSN N/A
- ICG $25.61
- Revenue Growth
- MRSN N/A
- ICG 384.54
- 52 Week Low
- MRSN $0.26
- ICG $1.19
- 52 Week High
- MRSN $2.83
- ICG $12.04
- Technical
- Relative Strength Index (RSI)
- MRSN 36.52
- ICG 53.27
- Support Level
- MRSN $0.27
- ICG $1.57
- Resistance Level
- MRSN $0.36
- ICG $2.21
- Average True Range (ATR)
- MRSN 0.03
- ICG 0.30
- MACD
- MRSN -0.01
- ICG 0.05
- Stochastic Oscillator
- MRSN 11.85
- ICG 80.39
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.